IOVA insider transactions

Interim CEO & General Counsel Vogt Frederick G converted options into 41,668 shares and covered exercise/tax liability with 17,701 shares, increasing direct ownership by 5% to 553,505 units (SEC Form 4) (withholding obligation)

Chief Regulatory Officer Puri Raj K. covered exercise/tax liability with 2,508 shares and converted options into 5,469 shares, increasing direct ownership by 1% to 242,191 units (SEC Form 4) (tax liability)

Chief Medical Officer Graf Finckenstein Friedrich covered exercise/tax liability with 4,473 shares and converted options into 8,790 shares, increasing direct ownership by 3% to 136,274 units (SEC Form 4) (withholding tax)

Chief Operating Officer Bilinsky Igor converted options into 8,790 shares and covered exercise/tax liability with 4,473 shares, increasing direct ownership by 3% to 130,083 units (SEC Form 4) (tax withholding)

Chief Commercial Officer Kirby Daniel Gordon converted options into 10,000 shares and covered exercise/tax liability with 2,435 shares, increasing direct ownership by 5% to 146,946 units (SEC Form 4) (tax withholding)

SEC Form 4 filed by Chief Financial Officer Roche Corleen M.

SEC Form 4 filed by Iovance Biotherapeutics Inc.

SEC Form 4 filed by Iovance Biotherapeutics Inc.

SEC Form 4 filed by Iovance Biotherapeutics Inc.

SEC Form 4 filed by Iovance Biotherapeutics Inc.

SEC Form 4 filed by Iovance Biotherapeutics Inc.

Interim CEO & General Counsel Vogt Frederick G converted options into 62,493 shares and covered exercise/tax liability with 26,755 shares, increasing direct ownership by 7% to 529,538 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich converted options into 31,246 shares and covered exercise/tax liability with 16,520 shares, increasing direct ownership by 13% to 131,957 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. converted options into 39,059 shares and covered exercise/tax liability with 18,360 shares, increasing direct ownership by 9% to 239,230 units (SEC Form 4)

Chief Operating Officer Bilinsky Igor converted options into 31,246 shares and covered exercise/tax liability with 16,628 shares, increasing direct ownership by 13% to 125,766 units (SEC Form 4)

Interim CEO & General Counsel Vogt Frederick G covered exercise/tax liability with 22,809 shares and converted options into 52,087 shares, increasing direct ownership by 6% to 493,800 units (SEC Form 4)

Chief Operating Officer Bilinsky Igor converted options into 12,307 shares and covered exercise/tax liability with 6,903 shares, increasing direct ownership by 5% to 111,148 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. converted options into 5,470 shares and covered exercise/tax liability with 2,798 shares, increasing direct ownership by 1% to 218,531 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich covered exercise/tax liability with 7,122 shares and converted options into 12,697 shares, increasing direct ownership by 5% to 117,231 units (SEC Form 4)

SEC Form 4 filed by Iovance Biotherapeutics Inc.

Chief Commercial Officer Kirby Daniel Gordon converted options into 39,996 shares and covered exercise/tax liability with 16,450 shares, increasing direct ownership by 78% to 53,546 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich converted options into 12,695 shares and covered exercise/tax liability with 6,448 shares, increasing direct ownership by 6% to 111,656 units (SEC Form 4)

Chief Operating Officer Bilinsky Igor covered exercise/tax liability with 6,250 shares and converted options into 12,305 shares, increasing direct ownership by 6% to 105,744 units (SEC Form 4)

Interim CEO & General Counsel Vogt Frederick G converted options into 52,086 shares and covered exercise/tax liability with 22,127 shares, increasing direct ownership by 7% to 464,522 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. converted options into 5,469 shares and covered exercise/tax liability with 2,467 shares, increasing direct ownership by 1% to 215,859 units (SEC Form 4)

Interim CEO & General Counsel Vogt Frederick G converted options into 52,086 shares and covered exercise/tax liability with 22,127 shares, increasing direct ownership by 7% to 434,563 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. covered exercise/tax liability with 2,467 shares and converted options into 5,470 shares, increasing direct ownership by 1% to 212,857 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich converted options into 12,697 shares and covered exercise/tax liability with 6,448 shares, increasing direct ownership by 6% to 105,409 units (SEC Form 4)

Chief Operating Officer Bilinsky Igor converted options into 12,306 shares and covered exercise/tax liability with 6,250 shares, increasing direct ownership by 6% to 99,689 units (SEC Form 4)

SEC Form 4 filed by Chief Financial Officer Roche Corleen M.

SEC Form 3 filed by new insider Roche Corleen M.

New insider Rosinack Matthew W. claimed ownership of 89,129 shares (SEC Form 3)

SEC Form 4 filed by Director Countouriotis Athena

SEC Form 4 filed by Director Maynard Ryan D

SEC Form 4 filed by Director Weiser Michael

SEC Form 4 filed by Director Dukes Iain D.

SEC Form 4 filed by Director Yarno Wendy L

Chief Commercial Officer Kirby Daniel Gordon bought $55,200 worth of shares (30,000 units at $1.84) (SEC Form 4)

Chief Regulatory Officer Puri Raj K. converted options into 5,469 shares and covered exercise/tax liability with 2,467 shares, increasing direct ownership by 1% to 209,854 units (SEC Form 4)

Interim CEO & General Counsel Vogt Frederick G covered exercise/tax liability with 22,127 shares and converted options into 52,085 shares, increasing direct ownership by 8% to 404,604 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich converted options into 12,695 shares and covered exercise/tax liability with 6,448 shares, increasing direct ownership by 7% to 99,160 units (SEC Form 4)

Chief Operating Officer Bilinsky Igor converted options into 12,305 shares and covered exercise/tax liability with 6,250 shares, increasing direct ownership by 7% to 93,633 units (SEC Form 4)

Chief Financial Officer Bellemin Jean-Marc covered exercise/tax liability with 4,464 shares and converted options into 8,789 shares, increasing direct ownership by 8% to 60,529 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. bought $9,743 worth of shares (5,600 units at $1.74), increasing direct ownership by 3% to 206,852 units (SEC Form 4)

Interim CEO & General Counsel Vogt Frederick G bought $42,250 worth of shares (25,000 units at $1.69), increasing direct ownership by 7% to 374,646 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. converted options into 8,334 shares and covered exercise/tax liability with 2,509 shares, increasing direct ownership by 3% to 201,252 units (SEC Form 4)

SEC Form 4 filed by Interim CEO & General Counsel Vogt Frederick G

SEC Form 4 filed by Chief Regulatory Officer Puri Raj K.

SEC Form 4 filed by Chief Medical Officer Graf Finckenstein Friedrich

SEC Form 4 filed by Chief Operating Officer Bilinsky Igor

SEC Form 4 filed by Chief Financial Officer Bellemin Jean-Marc

Chief Financial Officer Bellemin Jean-Marc converted options into 58,590 shares and covered exercise/tax liability with 31,734 shares, increasing direct ownership by 92% to 56,204 units (SEC Form 4)

Chief Operating Officer Bilinsky Igor covered exercise/tax liability with 33,302 shares and converted options into 62,106 shares, increasing direct ownership by 49% to 87,578 units (SEC Form 4)

Interim CEO & General Counsel Vogt Frederick G converted options into 223,943 shares and covered exercise/tax liability with 95,413 shares, increasing direct ownership by 58% to 349,646 units (SEC Form 4)

Chief Regulatory Officer Puri Raj K. converted options into 59,999 shares and covered exercise/tax liability with 19,984 shares, increasing direct ownership by 26% to 195,427 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich converted options into 62,497 shares and covered exercise/tax liability with 33,470 shares, increasing direct ownership by 45% to 92,913 units (SEC Form 4)

SEC Form 4 filed by Chief Commercial Officer Kirby Daniel Gordon

SEC Form 3 filed by new insider Kirby Daniel Gordon

Interim CEO & General Counsel Vogt Frederick G converted options into 20,835 shares and covered exercise/tax liability with 9,955 shares, increasing direct ownership by 5% to 221,116 units (SEC Form 4)

Chief Medical Officer Graf Finckenstein Friedrich covered exercise/tax liability with 1,578 shares and converted options into 2,813 shares, increasing direct ownership by 2% to 63,886 units (SEC Form 4)